Guide Therapeutics, Inc.

New Filing
CIK: 0001769132·Biotechnology·DELAWARE·Filed: Aug 24, 2020
Total Offering

$5,862,139

Amount Sold

$5,862,139

Investors

3

First Sale

Aug 7, 2020

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2018
Non-Accredited Investors
No

Related Persons

NameRole
James Dahlman
Related Person
Robert Hershberg
Related Person
Andrew Perlman
Related Person
Julie Sunderland
Related Person

Company

Guide Therapeutics, Inc.

1860 MONTREAL ROAD

TUCKER, GA, 30084

509-863-3501

SEC Filing

0001769132-20-000004

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Guide Therapeutics, Inc. Form D Filing — $5,862,139 | FilingFlow